Cookies show us what works. Privacy
Cookies show us what works. Privacy
Nov 14, 2026: insiders filed 4 open-market buys of $25K or more across 3 companies. Over the last 7 days: 231 buys across 151 companies.
| Insider | Company | Bought | Traded | Filed |
|---|---|---|---|---|
| Jonathan Lee PollackDirector | STWD2 insidersStarwood Property Trust | $2.0M169,800 shares | ||
| Barry S SternlichtCEO, Chairman of the Board | STWD2 insidersStarwood Property Trust | $14.7M1,245,000 shares | ||
| David J AldrichDirector | INDIindie Semiconductor | $299K130,000 shares | ||
| Charles R. PattonDirector | CTRI2 insidersCenturi Holdings | $250K11,000 shares | ||
| Michael AbbateDirector | IONDIonic Digital | $1.3M19,642 shares | ||
| Jeffrey ArcaraChief Business Officer | CRVSCorvus Pharmaceuticals | $50K4,500 shares | ||
| Richard GaynorDirector | ZLABZai Lab | $33K1,228 shares | ||
| Travis DaltonPres., CEO & Executive ChairShares held by Spouse's Individual Retirement Account | CTEV2 insidersClaritev | $150K5,110 shares | ||
| Paul GuChief Executive Officer | UPSTUpstart Holdings | $1.0M50,000 shares | ||
| Amir F HeshmatpourCEO, President, 10% owner | NTHI2 insidersNeonc Technologies Holdings | $151K30,000 shares | ||
| Rehan JafferDirector | FUN3 insidersSix Flags Entertainment | $9.2M825,000 shares | ||
| Matt Mcgraner | NXRT2 insidersNexPoint Residential Trust | $100K6,365 shares | ||
| Eric L Oliver10% ownerShares held by SoftVest, LP | SJTSan Juan Basin Royalty Trust | $2.0M455,189 shares | ||
| Eugene S StarkVP Administration | GAMGeneral American Investors | $88K4,000 shares | ||
| Joseph A TatoDirector | BW5 insidersBabcock & Wilcox Enterprises | $53K10,000 shares | ||
| Kyle Steven BrownCEO, President and CIOShares held by The Kyle and Amy Brown Family Trust, dated February 4, 2019 | TRINTrinity Capital | $58K3,215.1 shares | ||
| William H LenehanPresident and CEO | FCPTFour Corners Property Trust | $150K6,468 shares | ||
| Richard DouglasDirector | ALDX2 insidersAldeyra Therapeutics | $129K200,000 shares | ||
| Jerome Benedict DursoPresident and CEO | ALT3 insidersAltimmune | $50K30,700 shares | ||
| F Thomson LeightonChief Executive Officer | AKAMAkamai Technologies | $2.6M30,000 shares | ||
| David MaclennanDirector | CAT2 insidersCaterpillar | $209K350 shares | ||
| Amy FreedmanDirector | KEEL2 insidersKeel Infrastructure | $76K40,000 shares | ||
| Michael Cannon-BrookesCEO, Co-Founder, 10% owner | TEAMAtlassian | $2.0M13,400 shares | ||
| Clark GolestaniDirector | ZPTAZapata Quantum | $30K40,000 shares | ||
| Michael R HaydenDirector | IONSIonis Pharmaceuticals | $148K5,000 shares | ||
| Donald C. BedellDirector | FF4 insidersFutureFuel | $113K40,000 shares | ||
| Pamela R ButcherDirector | FF4 insidersFutureFuel | $28K10,000 shares | ||
| Bob R SimpsonDirector, 10% owner | TXOTXO Partners | $945K67,161 shares | ||
| Roeland PoletChief Executive Officer | FF4 insidersFutureFuel | $136K48,080 shares | ||
| Gretchen Lynn HollowayDirector | KGS3 insidersKodiak Gas Services | $50K1,145 shares | ||
| Rose SparksChief Financial Officer | FF4 insidersFutureFuel | $30K10,750 shares | ||
| Alexander Newsom DardenDirector | KGS3 insidersKodiak Gas Services | $450K10,000 shares | ||
| Michael Bradley SmithDirector | TRTX3 insidersTPG RE Finance Trust | $65K10,000 shares | ||
| Mark T LammasPresident | HPP3 insidersHudson Pacific Properties | $44K5,000 shares | ||
| Assaf RanPresident and CEO, 10% owner | LOANManhattan Bridge Capital | $32K10,000 shares | ||
| Timothy T YatesDirector | VISN2 insidersVistance Networks | $99K25,000 shares | ||
| Eric C NeumanDirector | DTI5 insidersDrilling Tools International | $66K37,267 shares | ||
| John SimardDirector, 10% owner | XBITXBiotech | $143K70,000 shares | ||
| Richard BeckwittDirector | WYWeyerhaeuser | $307K15,000 shares | ||
| Mahesh Patel VChief Executive Officer | LPCNLipocine | $79K50,000 shares | ||
| John Earl JacksonDirector | NGSNatural Gas Services Group | $58K2,000 shares | ||
| Kenneth M YoungChief Executive Officer | BW5 insidersBabcock & Wilcox Enterprises | $44K10,000 shares | ||
| Alejandro Gustavo ElsztainDirector | CRESYCresud | $89K100,000 shares | ||
| Andrew BoothChief Financial Officer | ABCL2 insidersAbCellera Biologics | $97K8,600 shares | ||
| Anne L MariucciDirector | CTRI2 insidersCenturi Holdings | $100K4,545 shares | ||
| Alexander DimitriefDirector | EOSEEos Energy Enterprises | $47K25,000 shares | ||
| Markus PuhlmannChief Medical Officer | CATX2 insidersPerspective Therapeutics | $35K41,000 shares | ||
| John F BarryChief Executive Officer, 10% owner | PSEC2 insidersProspect Capital | $6.1M4,014,895 shares | ||
| Steven R. E. CookChief Financial Officer | CSQR3 insidersCsquare | $35K2,027.805 shares | ||
| Ziyu ShenChief Executive Officer | ECXECARX Holdings | $234K300,000 shares | ||
| Anton Jose Antonio PerezDirectorShares held by Piriply, S.A. de C.V. | ASRSoutheast Airport Group | $498K1,875 shares | ||
| Thomas Edward HamiltonDirectorShares held by Cure FA Foundation, Inc. | LRMR7 insidersLarimar Therapeutics | $187K70,000 shares | ||
| Jon E BortzDirector | HPP3 insidersHudson Pacific Properties | $680K75,000 shares | ||
| Victor J ColemanChief Executive Officer | HPP3 insidersHudson Pacific Properties | $182K20,000 shares | ||
| Claudius E. Watts IVDirector | VISN2 insidersVistance Networks | $198K50,000 shares | ||
| Claudius E. Watts IVDirector | VISN2 insidersVistance Networks | $831K200,000 shares | ||
| Sharon L WienbarDirector | ENOV2 insidersEnovis | $50K1,774 shares | ||
| Angela S LalorDirector | ENOV2 insidersEnovis | $50K1,757 shares | ||
| Leslie J ParretteDirector | IOSPInnospec | $27K345 shares | ||
| Sardar BiglariChairman and CEO, 10% ownerShares held by The Lion Fund, L.P. | BHBiglari Holdings | $5.5M3,657 shares |
Jonathan Lee Pollack, Director
Traded Filed
Barry S Sternlicht, CEO, Chairman of the Board
Traded Filed
David J Aldrich, Director
Traded Filed
Charles R. Patton, Director
Traded Filed
Michael Abbate, Director
Traded Filed
Jeffrey Arcara, Chief Business Officer
Traded Filed
Richard Gaynor, Director
Traded Filed
Travis Dalton, Pres., CEO & Executive Chair
Shares held by Spouse's Individual Retirement Account
Traded Filed
Paul Gu, Chief Executive Officer
Traded Filed
Amir F Heshmatpour, CEO, President, 10% owner
Traded Filed
Rehan Jaffer, Director
Traded Filed
Matt Mcgraner
Traded Filed
Eric L Oliver, 10% owner
Shares held by SoftVest, LP
Traded Filed
Eugene S Stark, VP Administration
Traded Filed
Joseph A Tato, Director
Traded Filed
Kyle Steven Brown, CEO, President and CIO
Shares held by The Kyle and Amy Brown Family Trust, dated February 4, 2019
Traded Filed
William H Lenehan, President and CEO
Traded Filed
Richard Douglas, Director
Traded Filed
Jerome Benedict Durso, President and CEO
Traded Filed
F Thomson Leighton, Chief Executive Officer
Traded Filed
David Maclennan, Director
Traded Filed
Amy Freedman, Director
Traded Filed
Michael Cannon-Brookes, CEO, Co-Founder, 10% owner
Traded Filed
Clark Golestani, Director
Traded Filed
Michael R Hayden, Director
Traded Filed
Donald C. Bedell, Director
Traded Filed
Pamela R Butcher, Director
Traded Filed
Bob R Simpson, Director, 10% owner
Traded Filed
Roeland Polet, Chief Executive Officer
Traded Filed
Gretchen Lynn Holloway, Director
Traded Filed
Rose Sparks, Chief Financial Officer
Traded Filed
Alexander Newsom Darden, Director
Traded Filed
Michael Bradley Smith, Director
Traded Filed
Mark T Lammas, President
Traded Filed
Assaf Ran, President and CEO, 10% owner
Traded Filed
Timothy T Yates, Director
Traded Filed
Eric C Neuman, Director
Traded Filed
John Simard, Director, 10% owner
Traded Filed
Richard Beckwitt, Director
Traded Filed
Mahesh Patel V, Chief Executive Officer
Traded Filed
John Earl Jackson, Director
Traded Filed
Kenneth M Young, Chief Executive Officer
Traded Filed
Alejandro Gustavo Elsztain, Director
Traded Filed
Andrew Booth, Chief Financial Officer
Traded Filed
Anne L Mariucci, Director
Traded Filed
Alexander Dimitrief, Director
Traded Filed
Markus Puhlmann, Chief Medical Officer
Traded Filed
John F Barry, Chief Executive Officer, 10% owner
Traded Filed
Steven R. E. Cook, Chief Financial Officer
Traded Filed
Ziyu Shen, Chief Executive Officer
Traded Filed
Anton Jose Antonio Perez, Director
Shares held by Piriply, S.A. de C.V.
Traded Filed
Thomas Edward Hamilton, Director
Shares held by Cure FA Foundation, Inc.
Traded Filed
Jon E Bortz, Director
Traded Filed
Victor J Coleman, Chief Executive Officer
Traded Filed
Claudius E. Watts IV, Director
Traded Filed
Claudius E. Watts IV, Director
Traded Filed
Sharon L Wienbar, Director
Traded Filed
Angela S Lalor, Director
Traded Filed
Leslie J Parrette, Director
Traded Filed
Sardar Biglari, Chairman and CEO, 10% owner
Shares held by The Lion Fund, L.P.
Traded Filed
| Insider | Company | Bought | Traded | Filed |
|---|---|---|---|---|
| Barry S SternlichtCEO, Chairman of the Board | STWD2 insidersStarwood Property Trust | $14.7M1,245,000 shares | ||
| John F BarryChief Executive Officer, 10% owner | PSEC2 insidersProspect Capital | $6.1M4,014,895 shares | ||
| Sardar BiglariChairman and CEO, 10% ownerShares held by The Lion Fund, L.P. | BHBiglari Holdings | $5.5M3,657 shares | ||
| F Thomson LeightonChief Executive Officer | AKAMAkamai Technologies | $2.6M30,000 shares | ||
| Michael Cannon-BrookesCEO, Co-Founder, 10% owner | TEAMAtlassian | $2.0M13,400 shares | ||
| Michael Cannon-BrookesCEO, Co-Founder, 10% owner | TEAMAtlassian | $2.0M13,400 shares | ||
| John F BarryChief Executive Officer, 10% owner | PSEC2 insidersProspect Capital | $1.7M1,222,704 shares | ||
| Blake D. MoretPresident and CEO | ROKRockwell Automation | $1.5M4,000 shares |
Barry S Sternlicht, CEO, Chairman of the Board
Traded Filed
John F Barry, Chief Executive Officer, 10% owner
Traded Filed
Sardar Biglari, Chairman and CEO, 10% owner
Shares held by The Lion Fund, L.P.
Traded Filed
F Thomson Leighton, Chief Executive Officer
Traded Filed
Michael Cannon-Brookes, CEO, Co-Founder, 10% owner
Traded Filed
The newest filing day in our data is shown above in UTC, which can be yesterday or earlier on a weekend. The list covers the last 7 days of filings, not trades made today. It includes reported open-market purchases by people of at least $25,000 and excludes grants and option exercises.